MDS Past President, Oscar S Gershanik (Favaloro Foundation University Hospital, Buenos Aires, Argentina) talked to us about dyskinesia in Parkinson’s disease, the topic of one of the plenary sessions he participated in during the congress.
1. What is the prevalence of levodopa-induced dyskinesias? (0:05)
2. What factors affect the development of dyskinesias? (0:44)
3. Could you give us a brief overview of the different types of dyskinesias? (1:56)
4. What are the major challenges in the clinical recognition of dyskinesia? (3:46)
5. What is the impact of levodopa-induced dyskinesias on health care utilisation? (4:52)
Speaker disclosure: Oscar S Gershanik has nothing relevant to disclose in relation to this video interview.
Filmed at the International Congress of Parkinson’s Disease and Movement Disorders (MDS), Nice, France, September 2019.
Share this Video
Related Videos In Parkinson's Disease
Veronica Clark, Parkinson’s Europe: Presidential Update, and the Parkinson’s Manifesto for Europe
The European Parkinson’s Disease Association (EPDA) recently changed its name to Parkinson’s Europe. They are the only European Parkinson’s umbrella organisation and have been working with the global Parkinson’s community for nearly 30 years. As a leading voice for Parkinson’s in Europe, they provide trusted information; advance and share good practices; raise awareness and improve […]
Suman Kushwaha, MDS 2022: COVID-19 vaccine induced parkinsonism and cognitive dysfunction
Two cases of COVID-19 vaccination associated neurological symptoms were presented, with patients displaying parkinsonism and cognitive dysfunction. In this touchNEUROLOGY interview, we speak with Dr Suman Kushwaha (Institute of Human Behaviour and Allied Sciences (IHBAS), Dilshad Garden, Delhi, India) to discuss the neurological symptoms and investigations leading to the case report conclusions. The abstract entitled […]
Suman Kushwaha, MDS 2022: Neurological symptoms and COVID-19 vaccination
Neurological complications, such as peripheral neuropathy, have been associated with COVID-19 vaccination. In this touchNEUROLOGY interview, we speak with Dr Suman Kushwaha (Institute of Human Behavior and Allied Sciences (IHBAS), Dilshad Garden, Delhi, India) to discuss the neurological symptoms that have been observed. The abstract entitled ‘Covid vaccine induced parkinsonism and cognitive dysfunction’ was presented […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!